UO Chirurgia 2, Azienda Ospedaliera San Paolo - Dipartimento di Medicina, Chirurgia ed Odontoiatria, Università degli Studi di Milano.
Ultrasound Med Biol. 2011 Jan;37(1):7-15. doi: 10.1016/j.ultrasmedbio.2010.10.007. Epub 2010 Nov 16.
Despite the high complete necrosis rate of radio-frequency ablation (RFA) or the complete removal following curative hepatic resection (HR), recurrent hepatocellular carcinoma (HCC) remains a significant problem. The aim of the study is to identify some intraoperative ultrasound (IOUS) patterns, predicting intrahepatic recurrences. From January 1997 to July 2009, 410 patients with HCC were treated (162 HR and 248 RFA through a surgical access). All patients were submitted to IOUS examination: 148 IOUS were performed during the laparotomic access while 262 IOUS were performed during the laparoscopic access. Primary HCC was classified according to diameter, HCC pattern (nodular or infiltrative), echogenicity (hyper- or hypo-echoic), echotexture (homogeneous or inhomogeneous), capsular invasion, mosaic pattern, nodule in nodule aspect and infiltration of portal vessels. Number of HCC nodules was also considered. Multivariate analysis (Cox model) was performed to determine features associated with recurrent HCC using IOUS patterns that independently predicted recurrent HCC, a IOUS score was developed. The patients were followed for 3-127 months, (median follow-up: 21.5 months). In 220 patients (54%), intrahepatic recurrences occurred. In 155 patients (38%), distant intrahepatic recurrences arose in different segments at the primary tumor site. In 65 HCC cases (16%), local recurrences were found. At multivariate analysis, multiple nodules, HCC diameter (>20 mm), HCC pattern (infiltrative), hyperechoic nodule and portal infiltration were statistically significant for risk factor of intrahepatic recurrences. Therefore, a IOUS scoring system was calculated on the basis of multivariate analysis and identified three risk categories of patients: in group 1 recurrences occurred in 37%, group 2 in 46% and group 3 in 66% (p = 0.0001). IOUS is an accurate staging tool during "surgical" procedures. This study showed an added value of IOUS: it permitted to identify ultrasound patterns, which can predict the risk of HCC recurrences. The calculated IOUS score permits to intraoperatively evaluate the actual surgical choice and to program the best treatment strategies during the follow-up period.
尽管射频消融(RFA)或根治性肝切除(HR)后的完全坏死率很高,但肝癌(HCC)的复发仍然是一个严重的问题。本研究旨在确定一些术中超声(IOUS)模式,以预测肝内复发。
从 1997 年 1 月至 2009 年 7 月,对 410 例 HCC 患者进行了治疗(162 例 HR 和 248 例 RFA 通过手术途径)。所有患者均接受 IOUS 检查:148 次 IOUS 在剖腹手术时进行,262 次 IOUS 在腹腔镜手术时进行。原发性 HCC 根据直径、HCC 模式(结节状或浸润性)、回声(高或低回声)、回声纹理(均匀或不均匀)、包膜侵犯、马赛克模式、结节内结节和门静脉浸润进行分类。还考虑了 HCC 结节的数量。采用多变量分析(Cox 模型)确定与使用 IOUS 模式预测 HCC 复发的 HCC 相关特征,该模式独立预测 HCC 复发,建立了 IOUS 评分。
患者随访 3-127 个月(中位随访时间:21.5 个月)。在 220 例患者(54%)中发生了肝内复发。在 155 例患者(38%)中,原发性肿瘤部位的不同节段出现了远处肝内复发。在 65 例 HCC 病例(16%)中发现了局部复发。多变量分析显示,多发结节、HCC 直径(>20mm)、HCC 模式(浸润性)、高回声结节和门静脉浸润是肝内复发的危险因素。因此,根据多变量分析计算了 IOUS 评分系统,并确定了患者的三个风险类别:第 1 组复发率为 37%,第 2 组为 46%,第 3 组为 66%(p=0.0001)。
IOUS 是“手术”过程中的一种准确分期工具。本研究显示 IOUS 的附加价值:它允许识别可以预测 HCC 复发风险的超声模式。计算出的 IOUS 评分可以在手术过程中评估实际的手术选择,并在随访期间规划最佳的治疗策略。